SERPINE1 and metabolic dysfunction-associated steatotic liver disease: Therefore, the present study investigated the efficacy of TM5441, a novel and orally active small molecule inhibitor of PAI-1, in ameliorating high fat diet (HFD)-induced NAFLD.